Richard S. Greenberg - Jan 27, 2022 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Signature
Richard S. Greenberg
Stock symbol
NXEN
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 02:56 PM
Previous filing
Nov 29, 2021
Next filing
Sep 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common Stock Award +250K +5.97% 4.44M Jan 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Class A Warrant 1.06M Jan 27, 2022 common stock 1.06M $0.04 Direct
holding NXEN Class B Warrant 1.06M Jan 27, 2022 common stock 1.06M $0.04 Direct
holding NXEN Class C Warrant 1.06M Jan 27, 2022 common stock 1.06M $0.05 Direct
holding NXEN Convertible note 40K Jan 27, 2022 common stock 1.06M $0.04 Direct
holding NXEN Options to purchase common stock (right to buy) 150K Jan 27, 2022 common stock 150K $0.54 Direct
holding NXEN Options to purchase common stock (right to buy) 100K Jan 27, 2022 common stock 100K $0.66 Direct
holding NXEN Options to purchase common stock (right to buy) 2.5M Jan 27, 2022 common stock 2.5M $0.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.